Abstract

We report the first case of a simultaneous pancreas and renal transplantation, in Australia, in a 45 year old male with long standing human immunodeficiency virus infection, type 1 diabetes mellitus and diabetic nephropathy requiring haemodialysis. This patient experienced previous virological failure and subsequent resistance to most nucleoside and non-nucleoside reverse transcriptase inhibitors. However, using novel combinations of anti-retroviral agents, along with careful monitoring, successful outcomes were achieved during the peri and post transplantation period, with excellent pancreas and renal graft function at one year.

Highlights

  • Recent experiences suggest that transplantation can be safely conducted in patients with human immunodeficiency virus (HIV) infection

  • Most were on nucleoside reverse transcriptase inhibitor (NRTI) based regimes

  • The current case demonstrates that the presence of complex antiretroviral drug resistance patterns, requiring thoughtful antiretroviral treatment regimens, can be managed successfully to allow organ transplantation in HIV patients

Read more

Summary

Introduction

Eight cases of simultaneous pancreas and kidney (SPK) transplantation in HIV patients with type 1 diabetes mellitus (T1DM) have been reported with good outcomes [1,2,3,4,5]. All patients were under the age of 50 years, with undetectable HIV RNA blood levels. At the time of transplantation, CD4 count was 518 cells/mL, HIV viral load was undetectable and CMV and EBV IgG were negative. Therapeutic drug monitoring (TDM) allowed gradual escalation of the CI dose, with the aim to achieve adequate, yet safe, immunosuppression to optimise graft survival. TDF was replaced by Tenofovir alafenamide combined with emtricitabine, a new agent with reduced nephrotoxicity His general health improved, despite several admissions with psoas collection and a splenic infarct.

Discussion
Survival complications Patient Pancreas Kidney
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.